| Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
|---|
| 01/20/2005 | US20050014266 Transcription regulator for use in controlling vectoral expression of genes associated with conferring disease, freeze, salt resistance and drought resistant crops |
| 01/20/2005 | US20050014260 Fusion protein delivery system and uses thereof |
| 01/20/2005 | US20050014257 Modulation of C-reactive protein expression |
| 01/20/2005 | US20050014234 Genes from the corynebacterium glutamicum coding for regulatory proteins |
| 01/20/2005 | US20050014228 Cytokine receptor protein for use in identifying modulators which prevent hepatitis viral replication and infection; viricides |
| 01/20/2005 | US20050014225 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/20/2005 | US20050014223 Renilla GFP mutants with increased fluorescent intensity and spectral shift |
| 01/20/2005 | US20050014219 Genes encoding carotenoid compounds |
| 01/20/2005 | US20050014192 Methods and compositions for amplification of RNA sequences |
| 01/20/2005 | US20050014177 Nucleotide sequences coding high density lipoprotein regulatory molecule for use in diagnosis/prognosis, prevention and treatment of cardiovascular disorders |
| 01/20/2005 | US20050014173 Parkinson's disease markers |
| 01/20/2005 | US20050014167 Anterior gradient 2 homolog (AGR2) for use as to in identifying modulator for treatment of asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis, vision defects, inflammatory bowel and cell proliferative disorders |
| 01/20/2005 | US20050014160 Bioconjugates for detecting proteases such as beta-secretase and caspase; solid phase synthesis; high throughput assay; drug screening; kits |
| 01/20/2005 | US20050014147 Method and apparatus for three label microarrays |
| 01/20/2005 | US20050013817 Human SMAPK3-related gene variants associated with cancers |
| 01/20/2005 | US20050013815 Prevention and treatment of amyloidogenic disease |
| 01/20/2005 | CA2531434A1 Quantifying teichoic acids of streptococcus pneumoniae |
| 01/20/2005 | CA2530029A1 Mutant adeno-associated virus virions and methods of use thereof |
| 01/20/2005 | CA2527537A1 Modulation of c-reactive protein expression |
| 01/19/2005 | EP1498497A2 Method of nucleic acid analysis by mass spectrometry |
| 01/19/2005 | EP1497642A2 Gene amplification in cancer |
| 01/19/2005 | EP1497469A2 Assay for evaluation of activity of compounds against hcv using a novel detection system in the hcv replicon |
| 01/19/2005 | EP1497455A2 Detection of nucleic acid sequences by cleavage and separation of tag-containing structures |
| 01/19/2005 | EP1497454A2 Methods of diagnosis of cancer, compositions and methods of screening for modulators of cancer |
| 01/19/2005 | EP1497442A2 Biologic modulations with nanoparticles |
| 01/19/2005 | EP1497431A2 Improved bacillus host cell |
| 01/19/2005 | EP1497415A2 Cytokine receptor |
| 01/19/2005 | EP1497303A2 Reagents for monitoring nuclei acid amplification and methods of using same |
| 01/19/2005 | EP1496945A1 Mycoplasma polypeptides |
| 01/19/2005 | EP1496943A2 Oligomeric compounds having modified phosphate groups |
| 01/19/2005 | EP1154857A4 System, method and computer program product for automated fluid or gas delivery |
| 01/19/2005 | EP0943158B1 Affinity based self-assembly systems and devices for photonic and electronic applications |
| 01/19/2005 | CN1568373A RNA interference mediating small rna molecules |
| 01/19/2005 | CN1566364A PCR mark of yellow dwarf-resistant gene Bdv2 of wheat and use thereof |
| 01/19/2005 | CN1566363A Mitochondria molecular hereditary feature mark and method for identifying pure boer goat |
| 01/19/2005 | CN1566345A Homologous sequence linked with yellow dwarf-resistant gene Bdv2 and use thereof |
| 01/19/2005 | CN1566343A Method for making chitosan nanoparticle-pcDNA3.1-hVEGF gene complex |
| 01/19/2005 | CN1566155A Anti-SARS monoclonal antibody, encoding sequence and application thereof |
| 01/19/2005 | CN1566134A Non-structural protein gene of coronavirus and use thereof |
| 01/19/2005 | CN1566133A Artificial traction fiber protein gene and cascade method and expression thereof |
| 01/19/2005 | CN1566132A Schizophrenia susceptible gene----KPNB3 gene and uses thereof |
| 01/19/2005 | CN1566131A Small interference RNA molecule SiRNA capable of attacking human hepatitis B virus and application thereof |
| 01/19/2005 | CN1185346C Oligonucleotide for detecting salmonellae |
| 01/19/2005 | CN1185343C New growth-differentiation factor of the TGF-beta family |
| 01/19/2005 | CN1185248C Ribosomal deactivated protein gene |
| 01/18/2005 | US6844433 Nucleic acid labeling compounds |
| 01/18/2005 | US6844327 Gene therapy approaches to supply apolipoprotein A-I agonists and their use to treat dyslipidemic disorders |
| 01/18/2005 | US6844324 Having membrane fusion component comprising antennapedia binding domain motif or functional equivalent; lysine and aspartic acid attachment of each component; can accomodate large DNA molecules |
| 01/18/2005 | US6844189 Chromosome 17P-linked prostate cancer susceptibility gene |
| 01/18/2005 | US6844176 Replicatable nucleic acid coding aspartokinase for biosynthesis of lysine for use in animal feeds, cosmetics and food processing |
| 01/18/2005 | US6844171 Oligomerization of hepatitis delta antigen |
| 01/18/2005 | US6844159 Genetic markers for screening animals for improved disease resistance (NRAMP) |
| 01/13/2005 | WO2005003375A2 Methods of amplifying and sequencing nucleic acids |
| 01/13/2005 | WO2005003371A2 Erk7 and erk8, novel diagnostic markers for cancer |
| 01/13/2005 | WO2005003339A1 Food additive comprising pseudomonas non-maltogenic exoamylase variants |
| 01/13/2005 | WO2005003326A2 Artificial receptors including reversibly immobilized building blocks and methods |
| 01/13/2005 | WO2005003315A2 Compositions and methods for peptide-assisted transfection |
| 01/13/2005 | WO2005003314A2 A method of selecting an active oligonucleotide predictive model |
| 01/13/2005 | WO2005003299A2 Polynucleotides encoding novel guanylate binding proteins (gbp's) |
| 01/13/2005 | WO2005003296A2 Albumin fusion proteins |
| 01/13/2005 | WO2005003293A2 pRNA CHIMERA |
| 01/13/2005 | WO2005003291A2 Bead bound combinatorial oligonucleoside phosphorothioate and phosphorodithioate aptamer libraries |
| 01/13/2005 | WO2005003289A2 Ap1 amine oxidase variants |
| 01/13/2005 | WO2005003159A1 Complement depletion using recombinant human c3-derivatives |
| 01/13/2005 | WO2005003154A2 Compositions and methods for the diagnosis and treatment of tumor |
| 01/13/2005 | WO2005002418A2 Mptens as modifiers of the pten/igf pathway and methods of use |
| 01/13/2005 | WO2005002414A2 Prognosis determination in ewing sarcoma patients by means of genetic profiling |
| 01/13/2005 | WO2004099409A8 Process for extracting nucleic acid |
| 01/13/2005 | WO2004074815A3 Predicting graft rejection |
| 01/13/2005 | WO2004069191A3 Identification of t1r and t2r modulators |
| 01/13/2005 | WO2004068116A3 Receptor deorphanization using tagged molecular libraries |
| 01/13/2005 | WO2004044135A3 Structural motifs and oligomeric compounds and their use in gene modulation |
| 01/13/2005 | WO2004044131A3 Cross-linked oligomeric compounds and their use in gene modulation |
| 01/13/2005 | US20050010974 Promoters for regulation of gene expression in plant roots |
| 01/13/2005 | US20050010043 Recombinant flavivirus for use in generation of vaccines to prevent and treat hemorrhagic fever |
| 01/13/2005 | US20050010030 Nucleotide sequences comprising lymphocyte receptor for use in generating immunoglobulin which suppress or prevent activation or proliferation of v-beta response; immunotherapy and treatment of joint inflammation |
| 01/13/2005 | US20050010029 Using nucleotide sequence cleavage, rearrangement and ligation to generate novel protein libraries for as tool in evaluating and screening drugs; peptide mimetics; directed evolution of proteins |
| 01/13/2005 | US20050009774 Immunomodulatory oligonucleotides |
| 01/13/2005 | US20050009750 Fibroblast growth factor receptors and methods for their use |
| 01/13/2005 | US20050009749 Also a gene encoding the protein and a Streptomyces sp. strain producing it; used to treat neurodegenerative disorders like Alzheimer's disease and Down syndrome |
| 01/13/2005 | US20050009745 TSG101 as inhibitor of HIV production |
| 01/13/2005 | US20050009174 Detection of nucleic acid hybridization by fluorescence polarization |
| 01/13/2005 | US20050009149 Trimeric tumor necrosis factor receptors for use as modulator for treatment of rheumatoid arthritis, atherosclerosis, osteoporosis, allograft rejection, cancer, inflammatory bowel and autoimmune diseases |
| 01/13/2005 | US20050009140 Elongase genes and uses thereof |
| 01/13/2005 | US20050009137 Intracellular estradiol binding protein, a polynucleotide encoding the same and cell lines overexpressing the same |
| 01/13/2005 | US20050009136 Pregnancy-associated plasma protein-A (PAPP-A) ligand for use as tool in identifying modulators for treatment and prevention of cell proliferative and cardiovascular disorders |
| 01/13/2005 | US20050009135 Transgenic yeast or fungi comprising nucleotide sequences coding phosphoglucomutase; for use as sources of enhanced ethanol fermentation |
| 01/13/2005 | US20050009129 Methods of screening for a candidate modulator of glucokinase |
| 01/13/2005 | US20050009092 Method and apparatus for conducting an array of chemical reactions on a support surface |
| 01/13/2005 | US20050009084 Detection of polymorphisms in the human 5-lipoxygenase gene |
| 01/13/2005 | US20050009077 Composition of matter comprising library of first nucleic acid analyte copies |
| 01/13/2005 | US20050009072 Genetic testing kits and a method of bladder cancer |
| 01/13/2005 | US20050009067 Expression profile of pancreatic cancer |
| 01/13/2005 | US20050009061 Anther-specific genes, their promoters, and uses of the same |
| 01/13/2005 | US20050009058 Nitro-substituted non-fluorescent asymmetric cyanine dye compounds |
| 01/13/2005 | US20050009056 Anti-infective therapy |
| 01/13/2005 | US20050009054 Compounds having a fused, bicyclic moiety for binding to the minor groove of dsDNA |
| 01/13/2005 | US20050009049 Expanding the eukaryotic genetic code |
| 01/13/2005 | US20050009044 Using topoisomerase (GYRA) nucleotide sequences as probes for detecting antibiotic resistant bacteria; diagnosing microrganismal infection |
| 01/13/2005 | US20050009043 Prodrugs of phosphonate nucleotide analogues |